ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751605 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751605; 2) Community: the network communities that were significantly associated with the response to NSC 751605; 3) Molecule: the relationships between components within communities and NSC 751605; 4) MDR: the compounds that were significantly associated with the NSC 751605.

NSC Compound Enrichment Correlation
NSC 736157 Null 0.0138010872611486 -0.28723232
NSC 740 Methotrexate 0.0138010872611486 0.47762021
NSC 749297 N'-{2-[2-(4-Methoxy-phenyl)-vinyl]quinazolin-4-yl}-N,N-dimethyl-propane-1,3-diamine hydrochloride 0.0138010872611486 0.14677849
NSC 5639 Null 0.0145418727063286 0.44379185
NSC 643724 Null 0.0145418727063286 -0.075675331
NSC 723397 Null 0.0145418727063286 0.45138908
NSC 750717 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one 0.0145418727063286 0.35027935
NSC 764043 (+)-JQ1 0.0145418727063286 -0.08433849
NSC 627991 Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- 0.0149636429145596 0.12276569
NSC 678125 1H-indazole, 3-methoxy-1-[(2-methoxyphenyl)methyl]- 5-nitro- 0.0149636429145596 -0.32147069
Total:79  Current:27    [First] [Prev] [Next] [Last]